OncoMyx lands $50m Series B led by Lumira, B Capital

The round was led by Canada's Lumira Ventures and US-based B Capital Group with participation from LYZZ Capital and all the company's Series A investors.

ByIris Dorbian

13 December 2021•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Canada North America US Healthcare Briefs

OncoMyx lands $50m Series B led by Lumira, B Capital

B Capital Group

Lumira Ventures

Boehringer Ingelheim Venture Fund

City Hill Ventures

Delos Capital

Korea Investment Partners

Xeraya Capital

Related articles